Services

Piedmont Research Center enables clients to use their budgets efficiently through in vivo efficacy evaluation of potential cancer therapies in human xenograft tumor models.

Human Tumor Xenografts

Our broad range of tumor lines, including several pairs of sensitive/resistant lines, ensures a wide variety of testing alternatives for a client's agent.

The model of choice can be used or our scientific staff can assist in selecting the most appropriate model for a client's agent. Complete profiling of agents can be carried out in a variety of tumor types or in combination with the appropriate clinical agent. Specially requested lines can be brought in if a model of interest is not among those listed below:

Human Tumor Xenograft
Tumor Type:Cell Line
Bladder:RT112, SW780
Brain:D54, SF-295, SK-N-AS, U87 MG
Breast:BT474, JIMT-1, MCF-7, MDA-MB-231, MX-1, ZR-75-1
Colon:COLO 205, DLD-1, HCT 116, HCT-15, HT-29, LoVo, LS-174T, SW-620, SW-480
Fibrosarcoma:HT-1080
Gastric:MKN-45, NCI-NC87, SNU-5
Head and Neck:FaDu, HONE-T-1
Leukemia/Lymphoma:Daudi, DoHH-2, Granta 519, HL-60, K-562, KG-1, MOLT-4, MV4-11, Namalwa, Raji B, Ramos, RL, WSU-DLCL2
Liver:Hep3B
Lung:A-427, A549, Calu-6, NCI-H125, H1975, NCI-H23, MV-522, NCI-H1299, NCI-H345, NCI-H460, NCI-H520, NCI-H522, NCI-H69, SK-MES-1
Melanoma:A2058, A375, Malme 3M, SK-MEL-5
Multiple Myeloma:H929, OPM-2, RPMI 8226
Osteosarcoma:SJSA-1
Ovarian:A2780, IGR-0V1, OV-CAR-3, SK-OV-3
Pancreas:BxPc-3, MIA PaCa-2, PANC-1
Prostate:22Rv.1, DU 145, MDAPCa 2b, PC3
Renal:786-0, A498, Caki-1, Caki-2, G-401, G-402
Thyroid:8505C, FTC-238
Vulvar/Epitheloid:A-431

Efficacy evaluation can be combined with:

- Hematology (CBC/Diff) analysis
- Pharmacokinetic or bioavailability sampling and analysis
- Histopathology or tissue sampling
- Biomarker screening, sampling or evaluation


Human Tumor Xenografts Human Tumor Xenografts
Human Tumor Xenografts

Murine Tumors
Tumor Type Cell Lines
Colon Colon26
Leukemia/Lymphoma L1210, P388
Lung Lewis Lung, Madison 109
Mammary 13672 (sc, orthotopic or intratibial); R3230Ac (intratibial)
Melanoma B16F10, B16F1
Sarcoma M5076